Citation and Traceability for IVD Diagnostic Reagent Pharmacovigilance

IVD diagnostic reagent pharmacovigilance data primarily originates from the National Medical Products Administration (NMPA) medical device adverse

Data Characteristics

IVD diagnostic reagent pharmacovigilance data primarily originates from the National Medical Products Administration (NMPA) medical device adverse event monitoring reports, manufacturer-submitted adverse event reports, clinical trial data, literature, and user feedback. Data update frequencies vary. NMPA reports typically release quarterly or annually, while enterprise reports follow real-time principles. Document structures often include PDF, Word, or structured database formats. PDF and Word documents are mostly unstructured or semi-structured text, containing natural language information such as adverse event descriptions, diagnostic results, and treatment measures. Structured databases have defined fields like product name, batch number, event date, adverse event type, involved organ system, severity, root cause analysis, and treatment recommendations. The data often includes medical terminology, abbreviations, and specific units of measurement, such as IU/mL and ng/dL.

Constraints Imposed by These Characteristics on Citation and Traceability

The complexity of IVD diagnostic reagent data sources requires a citation and traceability mechanism that handles multiple document formats. Unstructured text needs advanced text parsing and chunking strategies to ensure extracted information is complete and contextual semantics are preserved. Structured data requires precise mapping to knowledge base fields for subsequent querying and citation. Inconsistent update frequencies dictate that knowledge base content update strategies balance real-time and periodic updates to avoid citing outdated information. Specialized terminology and units of measurement in documents place higher demands on tokenizers and entity recognition models, ensuring accurate identification of key entities like product name and adverse event type. Additionally, fields like batch number directly impact the granularity of traceability, requiring fine-grained indexing support to locate specific batch-related reports and provide precise citation sources to users.

Configuration Settings

Configuration ItemSuggested ValueRationale
Chunk size (Chunk Length)300–500 charactersBalances contextual completeness of unstructured reports with recall efficiency
Chunk Overlap Length (Overlap Length)50 charactersEnsures semantic continuity across chunks, reducing information loss
Similarity threshold (Similarity Threshold)Calibrate based on actual measurementsRequires calibration based on the vector similarity distribution of IVD diagnostic reagent terminology
Recall count (Recall Count)top 8–12 entriesBalances recall breadth with performance overhead for subsequent re-ranking
Rerank result count (Re-ranked Return Count)top 3 entriesPrioritizes displaying the most relevant citations with traceability value
PARSE_FILE_TIMEOUT_SECONDS180 secondsAccommodates parsing time for large PDF or Word reports

Common Pitfalls

  • Missing key information in citation results, such as adverse event type or batch number, due to overly short text chunks or entity recognition models failing to extract correctly.
  • AI responses citing outdated adverse event reports because the knowledge base update mechanism did not synchronize the latest data released by NMPA or manufacturers in time.
  • System error Cannot redefine property: toString may occur if a custom parser has a naming conflict with internal system properties.

Verification Steps

  • Select a typical IVD diagnostic reagent adverse event report containing product name, adverse event type, event date, and batch number. Upload it and check if each chunk contains complete key information.
  • Verify that the knowledge base has synchronized the latest NMPA medical device adverse event monitoring reports and can correctly cite the original report links.
  • Query for a specific batch number from a report to confirm the system accurately recalls all related adverse event records for that batch and provides precise citation sources.

The values provided are common starting points and should be measured against the reader's own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.